VYLDA DM 100/10/1000 TAB

About

Vylda DM 100/10/1000 is a comprehensive triple-combination oral medication for the treatment of type 2 diabetes mellitus, featuring Vildagliptin, Dapagliflozin 10mg, and Metformin 1000mg. This formulation offers a robust approach to glycemic control by leveraging three distinct mechanisms of action. Vildagliptin enhances the body's natural ability to regulate blood glucose by increasing active incretin levels. Dapagliflozin works independently of insulin by promoting the excretion of excess glucose through the urine, thereby reducing blood sugar. Metformin, a foundational anti-diabetic agent, reduces glucose production by the liver and improves insulin sensitivity.

This combination is particularly suited for patients who require intensive glycemic management, have high baseline HbA1c, or have not achieved their target blood glucose levels with dual therapy, offering significant improvements in metabolic parameters and potential cardiovascular and renal benefits.

Uses

• Intensive management of type 2 diabetes.
• Achieving optimal glycemic control.
• When other therapies are insufficient.
• Reducing risk factors associated with diabetes.

Directions For Use

Take orally, usually once or twice daily with meals, as directed by your physician.

Benefits

• Powerful triple action for blood sugar control.
• Significant reduction in HbA1c and glucose levels.
• Potential for cardiovascular and renal protection.
• Contributes to modest weight reduction.
• Addresses multiple aspects of diabetes pathology.
• Convenient fixed-dose regimen for adherence.

Side Effects

• Genital mycotic infections.
• Urinary tract infections.
• Increased frequency of urination.
• Nausea, vomiting, diarrhea.
• Abdominal discomfort.
• Headache, dizziness.
• Hypoglycemia (especially with insulin/sulfonylureas).
• Lactic acidosis (rare, serious).
• Dehydration, orthostatic hypotension.
• Diabetic ketoacidosis (rare).
• Vitamin B12 deficiency.
• Back pain, arthralgia.

Safety Measures

• Alcohol - Avoid excessive alcohol intake due to increased risk of lactic acidosis (Metformin) and dehydration (Dapagliflozin).
• Pregnancy - Not recommended during pregnancy. Insulin is the preferred treatment. Dapagliflozin is contraindicated in the second and third trimesters.
• Breastfeeding - Avoid during breastfeeding as components may pass into breast milk. Consult your doctor.
• Liver - Contraindicated in severe liver impairment due to the Metformin component. Use with caution for Vildagliptin.
• Kidney - Contraindicated in severe renal impairment (eGFR <30 mL/min/1.73m²). Dose adjustment or discontinuation may be needed based on eGFR for all components.
• Lung - Use with caution in conditions causing hypoxia (e.g., severe lung disease, acute heart failure) due to increased risk of lactic acidosis with Metformin.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.